Aastha Chadha
About Aastha Chadha
Aastha Chadha is a scientist currently employed at Mirati Therapeutics in San Diego, California. She has a background in pharmaceutical sciences, with degrees from Panjab University and the University of Toledo, and has held various positions in the pharmaceutical industry.
Current Role at Mirati Therapeutics
Aastha Chadha currently works as a Scientist at Mirati Therapeutics, a position she has held since 2022. She is based in San Diego, California. In this role, she contributes to the development of innovative therapies, focusing on precision medicine. Her experience in pharmaceutical sciences supports her work in advancing the company's research initiatives.
Previous Experience at Catalent Pharma Solutions
Before joining Mirati Therapeutics, Aastha Chadha worked at Catalent Pharma Solutions as a Pharmaceutical Chemist III in Preformulation from 2020 to 2022. This role involved the development and optimization of drug formulations, enhancing her expertise in pharmaceutical chemistry and formulation strategies.
Professional Background at Murty Pharmaceuticals
Aastha Chadha served as a Quality Control Analytical Chemist at Murty Pharmaceuticals, Inc. from 2018 to 2020. Located in the Lexington, Kentucky area, her responsibilities included ensuring the quality and safety of pharmaceutical products through rigorous analytical testing.
Graduate Assistant Experience at The University of Toledo
Aastha Chadha was a Graduate Assistant in the Cosmetics Formulation Laboratory at The University of Toledo from 2016 to 2018. During this time, she gained hands-on experience in formulation science, contributing to research projects and assisting in laboratory operations.
Educational Background in Pharmaceutical Sciences
Aastha Chadha holds a Bachelor of Pharmacy (B.Pharm.) from Panjab University, completed from 2012 to 2016. She furthered her education with a Master of Science (MS) in Pharmaceutical Sciences (Industrial Pharmacy) from the University of Toledo, which she obtained from 2016 to 2018. Additionally, she has been studying at Harvard Business School Online since 2017, achieving the CORe: Credential of Readiness.